Works matching AU Oijordsbakken, Miriam

Results: 4
    1

    Osteopontin is a prognostic biomarker in non-small cell lung cancer.

    Published in:
    2013
    By:
    • Rud, Ane Kongsgaard;
    • Boye, Kjetil;
    • Øijordsbakken, Miriam;
    • Lund-Iversen, Marius;
    • Halvorsen, Ann Rita;
    • Solberg, Steinar K.;
    • Berge, Gisle;
    • Helland, Åslaug;
    • Brustugun, Odd Terje;
    • Mælandsmo, Gunhild M.;
    • Oijordsbakken, Miriam;
    • Helland, Aslaug
    Publication type:
    journal article
    2

    Beta-blockers prolong response to androgen deprivation therapy in prostate cancer through modulation of the neuro-immuno-oncology axis.

    Published in:
    Journal of Translational Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12967-025-06644-7
    By:
    • Thulin, Malin Hagberg;
    • Ramberg, Håkon;
    • Nielsen, Heidi Kristin;
    • Grytli, Helene Hartvedt;
    • Sivanesan, Shivanthe;
    • Pandya, Abhilash D.;
    • Seip, Kotryna;
    • Andressen, Kjetil Wessel;
    • Linder, Anna;
    • Øijordsbakken, Miriam;
    • Poutanen, Matti;
    • Katz, Betina;
    • Halvorsen, Bente;
    • Mælandsmo, Gunhild Mari;
    • Taskén, Kristin Austlid
    Publication type:
    Article
    3

    Osteopontin is a prognostic biomarker in non-small cell lung cancer.

    Published in:
    BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-540
    By:
    • Kongsgaard, Ane;
    • Boye, Kjetil;
    • Øijordsbakken, Miriam;
    • Lund-Iversen, Marius;
    • Halvorsen, Ann Rita;
    • Solberg, Steinar K;
    • Berge, Gisle;
    • Helland, Åslaug;
    • Brustugun, Odd Terje;
    • Mælandsmo, Gunhild M
    Publication type:
    Article
    4